Rapeseed protein as a novel ingredient of gluten-free bread von Korus, J., Chmielewska, A., Witczak, M., Ziobro, R., Juszczak, L.

Volltext

The effects of time, temperature and plant variety on pollen viability and its implications for gene flow risk von Brunet, J., Ziobro, R., Osvatic, J., Clayton, M. K., Elzenga, J.

Volltext

Pasting and rheological properties of oat starch and its derivatives von Berski, W., Ptaszek, A., Ptaszek, P., Ziobro, R., Kowalski, G., Grzesik, M., Achremowicz, B.

Volltext

Enrichment of wheat bread with apple pomace as a way to increase pro-health constituents von Gumul, D, Korus, J, Ziobro, R, Kruczek, M

Volltext

Rapeseed protein as a novel ingredient of gluten-free dough: Rheological and thermal properties von Witczak, M., Chmielewska, A., Ziobro, R., Korus, J., Juszczak, L.

Volltext

The influence of freeze-dried red and purple potatoes on content of bioactive polyphenolic compounds and quality properties of extruded maize snacks von Gumul, D, Areczuk, A, Ziobro, R, Ivanišová, E, Zięba, T

Volltext

Isolation, modification and characterization of soluble arabinoxylan fractions from rye grain von Buksa, Krzysztof, Ziobro, Rafał, Nowotna, Anna, Praznik, Werner, Gambuś, Halina

Volltext

THE ATTITUDES OF EUROPEAN CONSUMERS TOWARD INNOVATION IN BREAD; INTEREST OF THE CONSUMERS TOWARD SELECTED QUALITY ATTRIBUTES von LAMBERT, J.L., LE-BAIL, A., ZUNIGA, R., VAN-HAESENDONCK, I., VNZEVEREN, E., PETIT, C., ROSELL, M.C., COLLAR, C., CURIC, D., COLIC-BARIC, I., SIKORA, M., ZIOBRO, R.

Volltext

Starch bread with a share of non-wheat flours as a source of bioactive compounds in gluten-free diet von Ziobro, R, Gumul, D, Korus, J, Korus, A

Volltext

Changes in molecular mass and crystalline structure of starch isolated from immature cereals von Gumul, D, Gambus, H, Ziobro, R.,Krakow Agricultural University (Poland). Dept. of Carbohydrate Technology, Pikus, S.,Maria Curie-Sklodowska University, Lublin (Poland). Dept. of Crystallography

Volltext

The use of an alga Chlorella pyrenoidosa and a duckweed Lemna perpusilla as test organisms for toxicity bioassays of spent bleaching liquors and their components von Rowe, E.L., Ziobro, R.J., Wang, C.J.K., Dence, C.W.

Volltext

Reduced hippocampal inhibition and enhanced autism-epilepsy comorbidity in mice lacking neuropilin 2 von Eisenberg, Carol, Subramanian, Deepak, Afrasiabi, Milad, Ziobro, Patryk, DeLucia, Jack, Hirschberg, Pamela R., Shiflett, Michael W., Santhakumar, Vijayalakshmi, Tran, Tracy S.

Volltext

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma von Rini, Brian I, Plimack, Elizabeth R, Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzhanivska, Anna, Bondarenko, Igor, Azevedo, Sergio J, Borchiellini, Delphine, Szczylik, Cezary, Markus, Maurice, McDermott, Raymond S, Bedke, Jens, Tartas, Sophie, Chang, Yen-Hwa, Tamada, Satoshi, Shou, Qiong, Perini, Rodolfo F, Chen, Mei, Atkins, Michael B, Powles, Thomas

Volltext

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext

Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice von Henry, Brian D, Neill, Daniel R, Becker, Katrin Anne, Gore, Suzanna, Bricio-Moreno, Laura, Ziobro, Regan, Edwards, Michael J, Mühlemann, Kathrin, Steinmann, Jörg, Kleuser, Burkhard, Japtok, Lukasz, Luginbühl, Miriam, Wolfmeier, Heidi, Scherag, André, Gulbins, Erich, Kadioglu, Aras, Draeger, Annette, Babiychuk, Eduard B

Volltext

First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B von Suárez, C., Lee, J.-L., Ziobro, M., Gafanov, R.A., Matveev, V.B., Donskov, F., Pouliot, F., Alekseev, B.Y., Wiechno, P.J., Tomczak, P., Climent, M.A., Shin, S.J., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

Myasthenia Gravis Associated With Programmed Death-1 (PD-1) Receptor Inhibitor Pembrolizumab: A 40-day Case Report von Ziobro, Aidan S., LaPlante, Reid L., DeMari, Shayna R., Clark, Larissa M., Kingsley, David J., Smith, Alyssa J.

Volltext

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial von Eggermont, Alexander MM, Prof, Suciu, Stefan, PhD, Santinami, Mario, MD, Testori, Alessandro, MD, Kruit, Wim HJ, MD, Marsden, Jeremy, MD, Punt, Cornelis JA, Prof, Salès, François, MD, Gore, Martin, Prof, MacKie, Rona, Prof, Kusic, Zvonko, Prof, Dummer, Reinhard, Prof, Hauschild, Axel, Prof, Musat, Elena, MD, Spatz, Alain, MD, Keilholz, Ulrich, Prof

Volltext

662P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced non–clear cell renal cell carcinoma (nccRCC): Results after a minimum of 34 months of follow-up from KEYNO... von Lee, J-L., McDermott, D.F., Ziobro, M., Suarez, C., Langiewicz, P., Matveev, V.B., Wiechno, P., Gafanov, R., Tomczak, P., Pouliot, F., Donskov, F., Alekseev, B.Y., Shin, S.J., Bjarnason, G.A., Castellano, D., Liu, H., Burgents, J., Rodriguez-Lopez, K., Atkins, M.B.

Volltext

Endocannabinoids block status epilepticus in cultured hippocampal neurons von Deshpande, Laxmikant S., Blair, Robert E., Ziobro, Julie M., Sombati, Sompong, Martin, Billy R., DeLorenzo, Robert J.

Volltext